Premium
Mental health nursing is not for sale: rethinking nursing's relationship with the pharmaceutical industry
Author(s) -
LAKEMAN R.
Publication year - 2010
Publication title -
journal of psychiatric and mental health nursing
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.69
H-Index - 63
eISSN - 1365-2850
pISSN - 1351-0126
DOI - 10.1111/j.1365-2850.2009.01516.x
Subject(s) - citation , mental health , mental health nursing , psychology , nursing , medicine , library science , psychiatry , computer science
[Extract] The relationship between the pharmaceutical industry and medicine has long been acknowledged as ethically problematic and a topic for ongoing reflection and debate (Komesaroff & Kerridge 2002, Green 2008). Such debate has been minimal in nursing, but has become increasingly important as nursing has obtained prescriptive authority in many countries and constraints on health and education budgets have led to a greater reliance on pharmaceutical company sponsorship for education, research and professional activity. Bracken & Thomas (2009, p. 245) have argued that the credibility of the psychiatric profession has been brought into disrepute '...through the corruption of our research and training agendas by the interests of major drug companies in alliance with senior individuals from our profession'. Nursing as a profession needs to critically consider its relationship with the pharmaceutical industry now in order to maintain the respect and integrity it currently enjoys